Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Total Liabilities

$46.42M

Quarterly · Period ending: · USD

LCTX logo

LCTX Total Liabilities

Latest reported$46.42M
LCTX Quarterly Total Liabilities ($300.00K → $46.42M)
High-resolution chart · PNG

LCTX total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
46,422,000
56,838,000
69,238,000
68,843,000
43,687,000
34,098,000
36,206,000
31,800,000
35,927,000
37,493,000
38,996,000
39,493,000
40,430,000
44,190,000
51,728,000
53,595,000
54,423,000
59,302,000
83,647,000
11,623,000
11,153,000
11,358,000
12,822,000
12,906,000
14,387,000
14,124,000
14,231,000
17,459,000
19,932,000
22,479,000
9,414,000
6,519,000
7,500,000
7,940,000
8,978,000
12,880,000
15,168,000
15,519,000
12,064,000
11,333,000
10,275,000
20,522,000
18,213,000
15,925,000
14,659,000
12,191,686
12,178,141
16,700,072
19,401,015
12,585,674
15,467,429
5,485,246
5,376,466
5,314,799
5,454,220
3,658,741
4,087,028
3,146,847
4,371,514
3,958,997
4,588,265
4,084,981
3,847,002
2,384,629
2,504,176
2,284,958
2,386,082
5,119,754
6,611,447
6,635,790
5,382,271
5,846,564
4,530,363
3,911,327
3,221,491
2,906,441
2,837,290
2,739,198
2,515,728
2,399,565
2,365,387
2,386,741
2,155,365
1,682,839
1,469,661
1,154,270
1,176,819
755,607
827,499
578,940
3,502,096
3,125,730
3,003,252
3,187,517
2,667,227
2,320,356
2,283,619
2,014,244
2,040,469
3,452,232
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.